3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
5
Recruiting
3
Terminated
2
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
10
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
First-line Treatment
1
Colorectal Cancer Metastatic
1
Colonic Neoplasms
1
Clinical Stage III Gastric Cancer AJCC v8
1
Interventions
Fluorouracil
19
Oxaliplatin
17
Capecitabine
16
Leucovorin
14
Cisplatin
12
Irinotecan
11
Gemcitabine
11
Drug Therapy
11
Bevacizumab
10
pembrolizumab
9
Radiosurgery
9
Cetuximab
9
Docetaxel
8
Everolimus
7
spartalizumab
6
Sunitinib
6
Radiotherapy
6
Paclitaxel
6
Neoadjuvant Therapy
6
Cyclophosphamide
6
Trastuzumab
5
S 1 (combination)
5
Nivolumab
5
Immunotherapy
5
Immune Checkpoint Inhibitors
5
Chemotherapy, Adjuvant
5
Carboplatin
5
palbociclib
4
manganese chloride
4
Surgical Procedures, Operative
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Neoplasm Metastasis
×
trifluridine tipiracil drug combination
×
Clear all
NCT03909724
2020-11-13
SUNRISE-CRC
Amsterdam UMC, location VUmc
Phase 2/3
Unknown
60 enrolled